The hazards of retroviruses associated with monoclonal antibody production

Developments in Biological Standardization
|January 1, 1984
PubMed

Insights

Mammalian cells contain retroviral genetic information. Crude monoclonal antibody preparations may harbor these viruses, posing risks of oncogene activation and novel pathogen emergence, necessitating careful manufacturing and quality control.

Area of Science:

  • Molecular Biology
  • Virology
  • Immunology

Background:

  • Mammalian cells, particularly laboratory mice, harbor endogenous retroviral genetic information.
  • Murine cell lines, myeloma cell lines, and hybridomas frequently express retroviruses.
  • Crude monoclonal antibody preparations can contain significant numbers of retroviruses.

Purpose of the Study:

  • To highlight the potential risks associated with retroviruses in monoclonal antibody production.
  • To emphasize the need for stringent manufacturing and quality control procedures.
  • To inform about the pathogenic potential of retroviruses across species barriers.

Main Methods:

  • Review of existing literature on retroviral presence in mammalian cells and monoclonal antibody production.
  • Analysis of retroviral mechanisms for oncogene activation and recombination.
  • Comparison of endogenous retroviral sequences with exogenous ones.

Main Results:

  • Retroviruses can activate or acquire oncogenes, and recombine to form pathogenic agents.
  • Retroviruses can cross species barriers, exhibiting different pathogenicity.
  • Crude monoclonal antibodies may contain infectious retroviruses.

Conclusions:

  • Careful manufacturing and quality control are essential for monoclonal antibody production, especially for medical and veterinary use.
  • Widespread retroviral inoculation carries the risk of creating new, transmissible pathogenic agents.
  • Understanding retroviral behavior is critical to prevent unintended consequences in biological products.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...